Peptide record

TPDB92505

cpp Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides modified_plain modified
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92505
cpp
Anticancer Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides
Cancer-related peptides Delivery and barrier-penetrating peptides
Peptipedia B3Pred BBPpredict CPPsite3.0 StackTHP StackTHPred TumorHoPe2.0
modified_plain
Yes
A 5-aa modified multi-activity (Anticancer, Blood-Brain Barrier, Cell-penetrating Peptides, and other sources) peptide sequence curated from Peptipedia, B3Pred, BBPpredict, and other sources, with an available 3D structural model.
C-terminal: Amidation Chemical: FITC at N-terminus via the 6-aminohexanoic acid linker.
Sequence
CGKRK-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
5 reviewed residue count
Amidation Activity
FITC at N-terminus via the 6-aminohexanoic acid linker. Activity
L Activity
Linear Activity
Free Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

Mb49 Cells And Murine Peritoneal Macrophages

Assay & Model

8 to 12-week-old female mice (C57BL/6 or BALB/c)
8 to 12-week-old female mice (C57BL/6 or BALB/c)

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Non-natural residues Linear L
Phage Display
Rhodamine B nanogel
Cytoplasm
CGKRK accumulated in cells almost 10-fold more efficiently than KAREC.
In vitro and in vivo